alagebrium has been researched along with sildenafil citrate in 1 studies
Studies (alagebrium) | Trials (alagebrium) | Recent Studies (post-2010) (alagebrium) | Studies (sildenafil citrate) | Trials (sildenafil citrate) | Recent Studies (post-2010) (sildenafil citrate) |
---|---|---|---|---|---|
83 | 10 | 31 | 5,862 | 956 | 2,319 |
Protein | Taxonomy | alagebrium (IC50) | sildenafil citrate (IC50) |
---|---|---|---|
cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 0.0036 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atlı, Ö; Burukoğlu, D; Ergun, B; Ilgın, S; Musmul, A; Sırmagül, B | 1 |
1 other study(ies) available for alagebrium and sildenafil citrate
Article | Year |
---|---|
Matrix metalloproteinases are possible targets in monocrotaline-induced pulmonary hypertension: investigation of anti-remodeling effects of alagebrium and everolimus.
Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Everolimus; Hypertension, Pulmonary; Male; Matrix Metalloproteinases; Monocrotaline; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Thiazoles; Vasodilator Agents | 2017 |